Published in Biochemistry on June 02, 1998
Structure of mammalian protein geranylgeranyltransferase type-I. EMBO J (2003) 1.28
Successful molecular dynamics simulation of the zinc-bound farnesyltransferase using the cationic dummy atom approach. Protein Sci (2000) 1.26
Farnesyl diphosphate analogues with omega-bioorthogonal azide and alkyne functional groups for protein farnesyl transferase-catalyzed ligation reactions. J Org Chem (2007) 1.21
Protein farnesyltransferase-catalyzed isoprenoid transfer to peptide depends on lipid size and shape, not hydrophobicity. Chembiochem (2008) 0.99
Farnesyl protein transferase inhibitors and other therapies targeting the Ras signal transduction pathway. Invest New Drugs (1999) 0.95
Computational studies of the farnesyltransferase ternary complex part I: substrate binding. Biochemistry (2005) 0.93
Farnesyltransferase--new insights into the zinc-coordination sphere paradigm: evidence for a carboxylate-shift mechanism. Biophys J (2004) 0.89
Computational studies of the farnesyltransferase ternary complex part II: the conformational activation of farnesyldiphosphate. Biochemistry (2007) 0.87
Finding a needle in the haystack: computational modeling of Mg2+ binding in the active site of protein farnesyltransferase. Biochemistry (2010) 0.85
Unraveling the mechanism of the farnesyltransferase enzyme. J Biol Inorg Chem (2004) 0.84
Lysine(164)alpha of protein farnesyltransferase is important for both CaaX substrate binding and catalysis. Biochem J (2001) 0.80
Identification of a farnesol analog as a Ras function inhibitor using both an in vivo Ras activation sensor and a phenotypic screening approach. Mol Cell Biochem (2013) 0.76
Novel route to chaetomellic acid A and analogues: serendipitous discovery of a more competent FTase inhibitor. Bioorg Med Chem (2012) 0.75
Identification of the genomic locations of duplicate nucleotide sequences in maize by analysis of restriction fragment length polymorphisms. Genetics (1988) 11.26
Competency development in public health leadership. Am J Public Health (2000) 3.84
Nucleotide sequence of the Akv env gene. J Virol (1982) 3.53
Clinically relevant end points and new drug approvals for myeloma. Leukemia (2007) 2.91
Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ (2000) 2.91
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma. Leukemia (2007) 2.76
Clinical course of solitary extramedullary plasmacytoma. Radiother Oncol (1999) 2.05
Day hospital versus admission for acute psychiatric disorders. Cochrane Database Syst Rev (2003) 1.75
Leginon: a system for fully automated acquisition of 1000 electron micrographs a day. Ultramicroscopy (1999) 1.75
Reliability of a urine dipstick in emergency department patients. Ann Emerg Med (1989) 1.61
Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy. Int J Radiat Oncol Biol Phys (1998) 1.56
The role of benzodiazepines in the treatment of insomnia: meta-analysis of benzodiazepine use in the treatment of insomnia. J Am Geriatr Soc (2001) 1.51
Magnetic resonance imaging in the staging of solitary plasmacytoma of bone. J Clin Oncol (1993) 1.44
Enhancement of experimental metastasis by tumor necrosis factor. J Exp Med (1993) 1.40
Histamine and peptic ulcer: influence of sample-taking on the precision and accuracy of fluorometric histamine assay in biopsies of human gastric mucosa. Agents Actions (1980) 1.34
Molecular cloning of a highly leukemogenic, ecotropic retrovirus from an AKR mouse. J Virol (1982) 1.27
Impact of complete remission with intensive therapy in patients with responsive multiple myeloma. Bone Marrow Transplant (2001) 1.27
Integrated in situ soil remediation technology: the lasagna process. Environ Sci Technol (1995) 1.24
Histamine content and mast cells in human gastric and duodenal mucosa. Agents Actions (1978) 1.24
Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care. Health Technol Assess (2001) 1.23
Identification of specific residues of human interleukin 2 that affect binding to the 70-kDa subunit (p70) of the interleukin 2 receptor. Proc Natl Acad Sci U S A (1988) 1.22
Single-dose therapy with trimethoprim-sulfamethoxazole for urinary tract infection in women. Rev Infect Dis (1982) 1.21
Monoclonal antibodies to E92, an endothelial cell surface antigen. Arteriosclerosis (1983) 1.21
PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma. Leukemia (2012) 1.15
The diagnosis and management of insomnia in clinical practice: a practical evidence-based approach. CMAJ (2000) 1.13
Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma. Ann Oncol (2005) 1.13
[Traumatic perforation of the small intestine--a rare complication of inguinal hernia]. Praxis (Bern 1994) (2000) 1.12
Translational regulation of the human cytomegalovirus pp28 (UL99) late gene. J Virol (1997) 1.10
Cardiac surgery in active, primary infective endocarditis. Chest (1970) 1.08
Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells. Br J Cancer (2005) 1.07
Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ. Hum Pathol (1999) 1.06
Refined crystal structure of mitochondrial malate dehydrogenase from porcine heart and the consensus structure for dicarboxylic acid oxidoreductases. Biochemistry (1994) 1.03
Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancer. Br J Cancer (2006) 1.02
Comparison of distribution of doxycycline in mice after oral and intravenous application measured by a high-performance liquid chromatographic method. Arzneimittelforschung (1981) 1.01
Close linkage with the RET protooncogene and boundaries of deletion mutations in autosomal dominant Hirschsprung disease. Hum Mol Genet (1993) 1.00
Peptide and peptide mimetic inhibitors of antigen presentation by HLA-DR class II MHC molecules. Design, structure-activity relationships, and X-ray crystal structures. J Med Chem (2000) 1.00
Comparative evaluation of the effects of tetracycline and doxycycline on blood and liver lipids on male and female mice. Arzneimittelforschung (1981) 1.00
Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma. Bone Marrow Transplant (2002) 1.00
H1 + H2-receptor antagonists for premedication in anaesthesia and surgery: a critical view based on randomized clinical trials with Haemaccel and various antiallergic drugs. Agents Actions (1980) 0.99
Imaging of myeloma bone disease--implications for staging, prognosis and follow-up. Acta Oncol (2000) 0.98
Immunologic correlates of spontaneous lymphocyte proliferation in human T-lymphotropic virus infection. Blood (1991) 0.96
Isolation of atypical mycobacteria from human sources and the effect of cortisone on their pathogenicity in mice. Isr J Med Sci (1967) 0.96
Prognostic value of cytogenetics in multiple myeloma. Br J Haematol (1998) 0.96
Outcome of polyarteritis nodosa and Churg-Strauss syndrome. An analysis of twenty-five patients. Arthritis Rheum (1994) 0.96
High expression of ras p21 correlates with increased rate of abnormal mitosis in NIH3T3 cells. Oncogene (1990) 0.96
Diagnosis and management of acute alcohol withdrawal. CMAJ (1999) 0.96
Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal. CMAJ (1999) 0.95
Intestinal diamine oxidase and histamine release in rabbit mesenteric ischemia. Gastroenterology (1981) 0.95
A phase 2 study of patupilone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: Canadian Urologic Oncology Group study P07a. Ann Oncol (2011) 0.94
Infection control in cystic fibrosis: practical recommendations for the hospital, clinic, and social settings. Am J Infect Control (2000) 0.94
Avoidance of transection of the palmar cutaneous branch of the median nerve in carpal tunnel release. J Hand Surg Am (1996) 0.94
Cholera-induced mucin secretion from rat intestine: lack of effect of cAMP, cycloheximide, VIP, and colchicine. Am J Physiol (1984) 0.94
Optimizing radiotherapy of orbital and paraorbital tumors: intensity-modulated X-ray beams vs. intensity-modulated proton beams. Int J Radiat Oncol Biol Phys (2000) 0.92
Load-bearing capacity of functioning alumina dental endosseous implants. J Dent Res (1976) 0.92
Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma. Bone Marrow Transplant (2004) 0.92
Determination of butyltin, cyclohexyltin and phenyltin compounds in beers and wines. Food Addit Contam (1992) 0.91
Formation of N-nitroso-N-methylurea in various samples of smoked/dried fish, fish sauce, seafoods, and ethnic fermented/pickled vegetables following incubation with nitrite under acidic conditions. J Agric Food Chem (2001) 0.91
Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease. Arthritis Rheum (1999) 0.90
Updating working memory for words: a PET activation study. Hum Brain Mapp (2000) 0.90
Impact of lenalidomide dose on progression-free survival in patients with relapsed or refractory multiple myeloma. Leukemia (2011) 0.90
Glucocorticoid sensitivity of T-cell lymphoblastic leukemia/lymphoma is associated with glucocorticoid receptor-mediated inhibition of Notch1 expression. Leukemia (2012) 0.89
Asymptomatic Waldenstrom's macroglobulinemia. Semin Oncol (2003) 0.89
Blue nevi and other melanotic lesions of the prostate: report of 3 cases and review of the literature. J Urol (1972) 0.89
Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors. Bioorg Med Chem Lett (2001) 0.89
Treatment of Waldenstrom's macroglobulinemia resistant to standard therapy with 2-chlorodeoxyadenosine: identification of prognostic factors. Ann Oncol (1995) 0.89
The alteration of surface charge characteristics of the vascular system by oral contraceptive steroids. Contraception (1974) 0.88
Levels of chlorinated hydrocarbon residues in Canadian human breast milk and their relationship to some characteristics of the donors. Food Addit Contam (1993) 0.87
Fish embryo cell cultures for derivation of stem cells and transgenic chimeras. Mol Mar Biol Biotechnol (1993) 0.87
Haematological and plasma biochemical values for healthy Yucatan micropigs. Lab Anim (1993) 0.87
Cross-cultural adaptation and validation of an Argentine Spanish Version of the Stanford Childhood Health Assessment Questionnaire. Arthritis Care Res (1998) 0.87
Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma. Bone Marrow Transplant (2001) 0.86
Cognitive impairment in patients suffering from relapsing-remitting multiple sclerosis with EDSS < or = 3.5. Acta Neurol Scand (2003) 0.86
Consolidation therapy of multiple myeloma with thalidomide-dexamethasone after intensive chemotherapy. Ann Oncol (2002) 0.85
Histamine release and hypotensive reactions in dogs by solubilizing agents and fatty acids: analysis of various components in cremophor El and development of a compound with reduced toxicity. Agents Actions (1982) 0.85
HyperCVAD for VAD-resistant multiple myeloma. Am J Hematol (1996) 0.85
RhoA/Rho-kinase, vascular changes, and hypertension. Curr Hypertens Rep (2001) 0.85
Differential diagnosis of monoclonal gammopathies. Arch Pathol Lab Med (1999) 0.85
Investigation on the possible formation of N-nitroso-N-methylurea by nitrosation of creatinine in model systems and in cured meats at gastric pH. J Agric Food Chem (2000) 0.85
Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis. J Rheumatol (1996) 0.85
Attention to social stimuli and facial identity recognition skills in autism spectrum disorder. J Intellect Disabil Res (2010) 0.85
Histamine content, diamine oxidase activity and histamine methyltransferase activity in human tissues: fact or fictions? Agents Actions (1984) 0.84
Primary therapy of multiple myeloma with paclitaxel (taxol). Ann Oncol (1994) 0.84
Assay and identification of histamine in human gastric aspirate by a fluorometric--fluoroenzymatic technique. Its application in patients with chronic duodenal ulcer. Agents Actions (1982) 0.84
Randomized trial of alpha-interferon or dexamethasone as maintenance treatment for multiple myeloma. Am J Hematol (2000) 0.84
Glucagon release precedes insulin release in response to common secretagogues. Diabetes (1976) 0.83
Feasibility and tolerance of pulsed dose rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys (1999) 0.83
Exclusion of linkage between RET and neuronal intestinal dysplasia type B. Am J Med Genet (1996) 0.83
Right ventricular conductance to establish closed-loop pacing. Eur Heart J (1992) 0.83
Formation of moniliformin by Fusarium sporotrichioides and Fusarium culmorum. Appl Environ Microbiol (1987) 0.83
Treatment of acute exacerbation of systemic lupus erythematosus with high-dose intravenous immunoglobulin. Rheumatology (Oxford) (2000) 0.82
[Coelioscopic treatment of pancreatic polycystic disease]. Ann Chir (2003) 0.82
Impact of mental fatigue on self-paced exercise. Int J Sports Med (2013) 0.82
The 2004 Italian legislation regulating assisted reproduction technology: a multicentre survey on the results of IVF cycles. Hum Reprod (2005) 0.82
Differential subcellular localization regulates c-Cbl E3 ligase activity upon Notch3 protein in T-cell leukemia. Oncogene (2009) 0.82